AGE), on the rate of progression of arterial stiffness in a prospective longitudinal study in patients on HD.
Materials and Methods

Study Design and Population
This is a single-center longitudinal observational study that was conducted at Center Hospitalier Universitaire de Québec-L'Hôtel-Dieu de Québec Hospital. The full description of the studied population is available in the online-only Data Supplement data. Briefly, 109 chronic kidney disease (CKD) patients on chronic HD underwent measurements of aortic and branchial stiffness as well as pulse wave profile analysis, at baseline and after a mean follow-up of 1.2 years. The study was approved by the Institutional Review Board (Comité d'Éthique de la recherche) and was conducted in accordance to the Declaration of Helsinki. All patients provided informed consent.
Hemodynamic Measurements
Hemodynamic measurements were performed after 15 minutes of rest in a supine position before the midweek dialysis session. In case of an arteriovenous fistula, measurements were performed on the contralateral arm. Brachial artery blood pressure (BP) was recorded using the oscillometric automatic sphygmomanometer BPM-100 (BP-Tru, Coquitlam, Canada). 16 We determined carotid-femoral pulse wave velocity (cf-PWV) and carotid-radial PWV (cr-PWV), using Complior SP system (Artech Medical). Three consecutive recordings were performed to determine the transit time by the maximal upstroke algorithm, followed by measurement of direct distance between the 2 probes. For the purpose of comparison with the reference values published, standard cf-PWV was obtained taking into account differences in the transit time using the maximal upstroke algorithm, and the overestimation of true distance by multiplying direct distance by 0.8. 17 An abnormal cf-PWV is defined as a standard cf-PWV that is superior to the decade-specific 90th percentile of normal subjects. 17 Central systolic BP, diastolic BP, mean BP, pulse pressure, systolic pressure time index, diastolic pressure time index, time of return of the reflected wave, central augmented pressure, and central augmentation index were determined by radial aplanation tonometry (SphygmoCor System) as previously described.
18
Biochemical Analysis
All blood samples were obtained before the midweek dialysis session and analyzed as detailed in the online-only Data Supplement methods.
Data Analysis
The detailed statistical analysis is available in the online-only Data Supplement methods.
Results
The baseline demographic and clinical parameters are shown in Table 1 . This is a representative dialysis population in terms of age (mean of 66 years), diabetes mellitus (45%), and atherosclerotic cardiovascular disease (53%).
Central Pulse Wave Profile and Arterial Stiffness
Baseline and follow-up hemodynamic parameters are shown in Table 2 . After a mean follow-up of 1.2±0. 4 Table 2 ). During the same period, cf-PWV increased (+1.09±2.37 m/s; P<0.001) whereas cr-PWV decreased (−0.71±1.37 m/s; P<0.001). Table 3 shows changes in cf-PWV and cr-PWV from the baseline and the annualized rate of changes of cf-PWV and cr-PWV after correction for hemodynamic variables.
Biochemical Parameters
Serum calcium, phosphate, and parathyroid hormone levels were relatively well controlled and did not change significantly over the observation period. Serum pentosidine, endothelin-1, and CRP were elevated, but remained stable over the observation period, except for a slight decrease in endothelin-1 levels ( Table 2) .
Determinants of Changes in Arterial Stiffness
Older patients (>65 years) had higher baseline cf-PWV and a lower cr-PWV (Table 4) , whereas patients with diabetes mellitus or established atherosclerotic cardiovascular disease had a significantly higher baseline cf-PWV. In contrast, the rate of changes in cf-PWV or cr-PWV did not change by these conditions even after adjustments for duration of follow-up and relevant hemodynamic parameters (Figure) .
A generalized estimating equation was used, taking into account repeated measures of hemodynamic parameters and baseline biological parameters, and showed that (Table 5) age, atherosclerotic cardiovascular disease, diabetes mellitus, dialysis vintage (log) are significant determinants of baseline aortic stiffness, but there was no significant time interaction with these variables. In addition, albumin, endothelin-1, and CRP (log) were not related to progression of aortic stiffness. However, higher plasma pentosidine (P=0.001) was associated with accelerated progression of aortic stiffness.
In a similar analysis, we examined the determinants of brachial stiffness and found that older subjects had a lower baseline brachial stiffness, but there were no significant impact of age on the degree of regression in brachial stiffness. However, there was a significant interaction between higher CRP and regression of brachial stiffness with time. We then evaluated whether this regression of brachial stiffness is an adaptative response to a high degree of aortic stiffness. Indeed, Results are means±SD or median (25th-75th percentiles). Comparisons were performed using paired t test, Wilcoxon signed-rank test, or McNemar test. AP at 75 indicates augmentation pressure adjusted for a heart rate of 75 beats per minute; Aix at 75, augmentation index adjusted for a heart rate of 75 beats per minute; cf-PWV, carotid-femoral pulse wave velocity; CRP, c-reactive protein; cr-PWV, carotid-radial pulse wave velocity; DPTI, diastolic pressure time index; HDL,high-density lipoprotein; LDL, low-density lipoprotein; PP, pulse pressure; SPTI, systolic pressure time index; TG, triglyceride; and Tr, time of wave return.
*Standard cf-PWV refers to adjustments performed for the maximal upstroke algorithm and direct distance measurement. †Abnormal cf-PWV is defined as the standard cf-PWV that is higher than the decade-specific 90th percentile of normal subjects.
by guest on April 8, 2017 http://hyper.ahajournals.org/ Downloaded from model 2 of Table 5 shows that patients with higher baseline cf-PWV showed a more important regression of brachial stiffness with time.
Medication
All patients received ≥1 antihypertensive medication. 
Discussion
This longitudinal study shows for the first time that, in HD patients, cf-PWV increases over time by an average of 0.84 m/s per year after adjustment for mean BP. At baseline, highly abnormal aortic stiffness was present in 43% of the patients, and this proportion increased to 54% at follow-up. The rate of progression of aortic stiffness was not related to age, diabetes mellitus, or atherosclerosis, but to high levels of pentosidine.
However, cr-PWV decreased significantly by 0.66 m/s per year after correction for changes in mean BP. Nevertheless, the overall central hemodynamic studies showed an increase in the augmentation index and systolic pressure time index, and deterioration in myocardial perfusion-workload ratio. Determination of arterial stiffness has been the subject of many cross-sectional studies, but few studies have examined the rate of progression of aortic and brachial stiffness in a prospective, longitudinal fashion. In one of such studies, Benetos et al 19 examined the rate of progression of aortic stiffness in normotensive and treated hypertensive patients. Their study showed an unadjusted rate of progression of cf-PWV by 0.081 m/s per year and 0.147 m/s per year, respectively, in normotensive and treated hypertensive subjects, with a higher rate of progression of aortic stiffness in patients over the age of 50 years. In addition, only in the hypertensive group, there was an accelerated progression of aortic stiffness with increasing levels of serum creatinine tertiles (increase of cf-PWV by 0.034, 0.142, and 0.248 m/s per year, respectively, for creatinine levels of <8 mg/dL, 8-10 mg/dL and >10 mg/dL). In the context of non-dialysis-dependent CKD patients, Briet et al 20 evaluated carotid and aortic stiffness in 180 patients at baseline, with repeated annual measurements over a 4-year period. They showed that carotid stiffness increased by 0.28 m/s per year whereas there was no significant progression of aortic stiffness (−0.01 m/s per year; P=0.89). In comparison with these studies, the rate of progression of aortic stiffness is much higher in our HD population. Although age, diabetes mellitus, and atherosclerotic cardiovascular disease had a significant impact on the baseline aortic stiffness in our study, we did not find any significant impact of these conditions on the rate of progression of aortic stiffness. In addition, we found no associations between total cholesterol, low-density lipoprotein, endothelin-1 (a marker of endothelial function), CRP (a marker of inflammation), statins, or inhibition of renin-angiotensin system, and the progression rate of aortic stiffness.
These findings suggest that traditional cardiovascular risk factors may play some role in the progression of aortic stiffness before development of advanced CKD, but the enhanced rate of progression of aortic stiffness in CKD patients on dialysis is probably determined by more specific CKD-related risk factors such as AGEs. Indeed, long-lived structural proteins such as collagen and elastin are particularly vulnerable to To obtain the adjusted annual rate of change, a forward conditional multiple linear regression was used through the origin with changes in mean blood pressure, changes in heart rate, and duration of follow-up as independent variables. Δcr-PWV indicates changes of carotid-radial pulse wave velocity from the baseline; Δcr-PWV adj , Δcr-PWV adjusted for changes in mean blood pressure and 1 y of follow-up; Δcf-PWV, changes of carotid-femoral pulse wave velocity from the baseline; and Δcf-PWV adj , Δcr-PWV adjusted for changes in mean blood pressure and 1 y of follow-up. Between-group differences have been tested by independent Student t test, and the P is reported in the column adjacent to the variable. cf-PWV indicates carotidfemoral pulse wave velocity; cr-PWV, carotid-radial pulse wave velocity; and CVD, cardiovascular disease. AGEs cross-links because of their slow rate of turnover. 21 In uremia, accumulation of reactive carbonyl compounds has been proposed to explain the plasma and tissue levels of AGEs in CKD. This process, known as carbonyl stress, is independent of glycemic control, and occurs through either oxidative or nonoxidative pathways in CKD. [22] [23] [24] [25] In fact, in vitro and animal models of diabetes mellitus and hyperglycemia have shown that AGEs cross-linking with elastin and collagen increases the slop of force-extension curve significantly, and that arterial stiffness is closely correlated with arterial content of pentosidine. 9, 10 Our findings show a significant association between serum pentosidine levels and progression of aortic stiffness, suggesting that AGEs could play a significant role in the progressive aortic stiffness in this population.
Furthermore, in light of the growing evidence that abnormal mineral metabolism may lead to vascular medial calcification and the ensuing vascular stiffness, we examined the relationship between mineral metabolism abnormalities and aortic stiffness. Our findings did not reveal any associations between calcium, phosphate, calcium-phosphate product, parathyroid hormone, and progression of aortic stiffness. Although phosphate is now recognized as a key player in the transdifferentiation of vascular smooth muscle cells into osteoblast-like cells, the lack of association of phosphate with progression of aortic stiffness may be the result of well-controlled phosphate levels in our patients.
Contrary to aorta, brachial artery is a muscular conduit artery, and cross-sectional studies suggest that brachial PWV increases with age, although to a much lesser extent than aortic PWV. 26 We therefore hypothesized that brachial PWV would either remain stable or progress very slowly in HD population. However, the cr-PWV decreased with time, suggesting that the reduction of brachial stiffness is an adaptive mechanism to compensate for the progressive stiffness of central elastic arteries. [27] [28] [29] In keeping with this hypothesis, our further analysis showed a strong association between baseline aortic stiffness and regression of brachial stiffness with time. Although brachial artery does not per se contribute significantly to the total arterial compliance, because of the large number of the medium-size muscular conduit arteries, it is conceivable that these arteries may contribute significantly to the total arterial compliance, especially in the presence of enhanced aortic stiffness. Indeed, the reversal of central to peripheral stiffness gradient attenuates proximal wave reflection and shifts reflecting sites distally, hence reducing the negative impact of wave reflection on central BP and cardiac workload. 29, 30 Overall, this is a typical dialysis population in terms of age, comorbidities (diabetes mellitus, hypertension, and cardiovascular disease), and pharmacological treatment (statin 57%, renin-angiotensin system inhibitors 36%, and aspirin 61%). Therefore, the overall rate of progression of aortic stiffness in our study represents the rate of progression of aortic stiffness with a well-controlled BP and various pharmacological interventions. We also acknowledge that the number of patients is relatively small to allow the detection of a smaller Model derived from generalized estimating equation, taking into account repeated measurements of hemodynamic parameters and baseline biological studies. cf-PWV indicates carotid-femoral pulse wave velocity; CI, confidence interval; CRP, c-reactive protein; cr-PWV, carotid-radial pulse wave velocity; CVD, cardiovascular disease; and MBP, mean blood pressure.
*Heart rate, PTH (log), endothelin-1, CRP (log), and the interaction of age, CVD, diabetes mellitus with follow-up time were removed from this model because they were not statistically significant.
†Atherosclerotic CVD, diabetes mellitus, dialysis vintage (log), PTH (log), endothelin-1, CRP (log), and the interaction of age, CVD, diabetes mellitus with time were removed from the model because they were not statistically significant. ‡Baseline cf-PWV, time and age-time interaction were removed from this model because they were not statistically significant. 
Perspective
In this study, age, diabetes mellitus, and atherosclerosis are strongly associated with higher baseline aortic stiffness. However, the accelerated progression of aortic stiffness was independent of age, status of diabetes mellitus, or atherosclerotic cardiovascular disease. These observations suggest these risk factors may have played a dominant role in the progression of aortic stiffness before beginning of dialysis, whereas more specific CKD-or dialysis-related risk factors may play the dominant role after initiation of dialysis. We have identified AGEs (pentosidine) to be an important factor in this study. Nevertheless, AGEs are not the only potential uremic toxins that could play a role in aortic stiffness, and further research is required to examine other potential pathways, such as vitamin K deficiency and disorders of CKD-related bone mineral metabolism. In addition, this study shows a reduction in brachial stiffness over the study period, presumably as an adaptative response to progressive aortic stiffness. This divergent change in aortic and brachial stiffness underlines the heterogeneity of conduit arteries and their response, at least, to the uremic milieu. The precise mechanism of this regression in brachial stiffness needs to be determined in the future, by the simultaneous assessment of both structural and functional properties of brachial artery, in a longitudinal fashion. Furthermore, we discourage the indiscriminate use of the term arterial stiffness, as it incorrectly implies homogeneity of the arterial tree. Finally, these finding are of major interest for the future development of noninvasive devices designed to measure aortic stiffness. 
